EBOS Group Completes $642m placement for LifeHealthcare
- EBOS Group (EBO) completes a placement, raising $642 million to partly fund its acquisition of LifeHealthcare
- The placement comprised 9.5 million new fully paid ordinary shares at NZ$34.50 (A$32.80) representing a 5.5 per cent discount to the last closing price
- EBO intends to conduct a non-underwritten retail offer to eligible existing shareholders to raise up to $100 million
- CEO John Cullity says through the acquisition of LifeHealthcare, EBO will accelerate its medical device strategy and capitalise on future growth opportunities
- On market close, EBOS is up 4.64 per cent and is trading at $36.31 per share
